Results 41 to 50 of about 47,575 (169)

Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan

open access: yesBMC Medical Ethics
Background Financial interactions between pharmaceutical companies and physicians lead to conflicts of interest. This study examines the extent and trends of non-research payments made by pharmaceutical companies to board-certified allergists in Japan ...
Anju Murayama, Yuki Senoo
doaj   +1 more source

The problem of unreasonably high pharmaceutical fees for patients in Chinese hospitals: A system dynamics simulation model

open access: yesComputers in Biology and Medicine, 2014
The social problem of unreasonably high pharmaceutical costs for patients in Chinese hospitals damages the interests of patients and it has a highly negative impact on the long-term development of the Chinese health service. We constructed a system dynamics model to address two problems, i.e., the unreasonably high prices of drugs and the high level of
Li, Meina   +4 more
openaire   +2 more sources

Analysis of US Food and Drug Administration new drug and biologic approvals, regulatory pathways, and review times, 1980–2022

open access: yesScientific Reports
U.S. laws enacted since 1983 have aimed to enhance the development and marketing of new pharmaceutical products. We thoroughly characterized all new molecular entities, therapeutic biologics, and gene and cell therapies approved by the US Food and Drug ...
Enrique Seoane-Vazquez   +2 more
doaj   +1 more source

Effectiveness of the kakaritsuke-yakuzaishi (family pharmacist) system for underage individuals in Japan: a cohort study using a health insurance claims database

open access: yesBMC Health Services Research
Background The kakaritsuke-yakuzaishi system (hereafter called the family pharmacist system), which provides more pharmaceutical services in exchange for higher fees than do general pharmacy practices, was introduced in Japan in April 2016.
Ryo Iketani
doaj   +1 more source

Estimation of the Cost-Saving for Inpatient and Pharmaceutical Expenses if a Diagnostic Related Group Payment System Had Been Established Instead of Fee-for-Service and Case-Mixed Payment Systems

open access: yes, 2022
Abstract Introduction: The second phase of Universal Health Coverage (UHC) was implemented in Iran in 2014. The purpose of this study was to estimate the amounts of cost-saving in inpatient and pharmaceutical costs in public hospitals if the Diagnostic Related Groups (DRG) payment system had been implemented instead of the Fee-for-Service (FFS)
Yousef Khadivi   +3 more
openaire   +1 more source

A DAG-enabled cryptographic framework for secure drug traceability with identity-bound authentication and anomaly detection

open access: yesScientific Reports
Counterfeit pharmaceuticals remain a major public health challenge, particularly in regions with limited regulatory enforcement and digital traceability systems.
Rajkumar S. C.   +6 more
doaj   +1 more source

Challenges faced by migrant populations in complying with public health measures during the COVID-19 pandemic in Malaysia: A qualitative study

open access: yesBMJ Public Health
Introduction The COVID-19 pandemic adversely impacted migrants in Malaysia, raising concerns about the effectiveness of public health measures. This study aims to investigate challenges faced by migrant populations in complying with public health ...
Tharani Loganathan   +6 more
doaj   +1 more source

Exploratory qualitative study to understand the underlying motivations and strategies of the private for-profit healthcare sector in urban Bangladesh

open access: yesBMJ Open, 2019
Objectives This paper explores the underlying motivations and strategies of formal small and medium-sized formal private for-profit sector hospitals and clinics in urban Bangladesh and their implications for quality and access.Methods This exploratory ...
Iqbal Anwar   +5 more
doaj   +1 more source

Remuneration for non-interventional studies – results of a survey in the pharmaceutical industry in Germany

open access: yesGMS German Medical Science, 2012
In 2007 the Association of Research-Based Pharmaceutical Companies (vfa) published recommendations to improve the quality and transparency of non-interventional studies. These recommendations include quality assurance measures, in particular with respect
Thorsten Ruppert   +2 more
doaj  

Home - About - Disclaimer - Privacy